4
Changes in Ownership
Outlook Therapeutics, Inc. Filed Acc 0001209191-21-011612
Chief Commercial Officer sold 56,973 shares at $2.55 ($145,281)
From the SEC's structured data for this filing
Trades in this filing
Evanson Jeff · Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-12 | Sale : show line 1 in the form | −56,973 | $2.55 | $145,281 | 1,150,484 | D |
| Open-market sales · 56,973 sh · avg $2.55 · $145,281 | ||||||
Loading xslF345X03/doc4.xml…